Circulating TNF receptor 2 is associated with the development of chronic kidney disease in non-obese Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 99, Issue 2, 2013, Pages 145-150

  Izumi, Yoshio ^a   Yabe, Daisuke ^b   Taniguchi, Ataru ^c   Fukushima, Mitsuo ^d   Nakai, Yoshikatsu ^e   Hosokawa, Masaya ^f   Okumura, Takahide ^g   Nin, Kazuko ^h   Matsumoto, Kazunari ⁱ   Nishimura, Fusanori ^j   Nagasaka, Shoichiro ^k   Seino, Yutaka ^b  

^a Department of Internal Medicine   (Japan)

^b KANSAI ELECTRIC POWER CO   (Japan)

^c Kyoto Preventive Medical Center   (Japan)

^d OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^e Kyoto Institute of Health Science   (Japan)

^f Tezukayamagakuin University   (Japan)

^g SAISEIKAI NAKATSU HOSPITAL   (Japan)

^h KYOTO UNIVERSITY   (Japan)

ⁱ SASEBO CHUO HOSPITAL   (Japan)

^j HIROSHIMA UNIVERSITY   (Japan)

^k JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

EGFR; Tumor necrosis factor; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BEZAFIBRATE; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEPTIN; SULFONYLUREA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; URIC ACID;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIET THERAPY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; JAPANESE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LEPTIN; MALE; MIDDLE AGED; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; RENAL INSUFFICIENCY, CHRONIC;

EID: 84876726360     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.11.002     Document Type: Article

References (35)

1. Bierman E.L. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 1992, 12:647-656.
2. Shai I., Schulze M.B., Manson J.E., Rexrode K.M., Stampfer M.J., Mantzoros C., et al. A prospective study of soluble tumor necrosis factor-α receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 2005, 28:1376-1382.
3. Kawasaki Y., Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Ohya M., et al. Soluble TNF receptors and albuminuria in non-obese Japanese type 2 diabetic patients. Horm Metab Res 2005, 37:617-621.
4. Ohgushi M., Taniguchi A., Fukushima M., Nakai Y., Kuroe A., Ohya M., et al. Soluble tumor necrosis factor receptor 2 is independently associated with pulse wave velocity in nonobese Japanese patients with type 2 diabetes. Metabolism 2007, 56:571-577.
5. Katakura M., Naka M., Kondo T., Nishi N., Komatsu M., Sato Y. Prospective analysis of mortality, morbidity, and risk factors in elderly diabetic subjects. Diabetes Care 2003, 26:638-644.
6. Astor B.C., Hallan S.I., Miller E.R., Yeung E., Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008, 167:1226-1234.
7. Huang H., Gandhi J.K., Zhong X., Wei Y., Gong J., Dub E.J., et al. TNFa is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protect vessels and neurons from apoptosis. Invest Ophthalmol Vis Sci 2011, 52:1336-1344.
8. World Health Organization. Diabetes mellitus: report of a WHO study group. WHO Tech. Rep. Ser. no. 727; 1998.
9. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
10. Yatagai T., Nagasaka S., Taniguchi A., Fukushima M., Nakamura T., Kuroe A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003, 52:1274-1278.
11. Taniguchi A., Nagasaka S., Fukushima M., Sakai M., Okumura T., Yoshii S., et al. C-reactive protein and insulin resistance in non-obese Japanese type 2 diabetes. Metabolism 2002, 51:1578-1581.
12. Taniguchi A., Fukushima M., Ohya M., Nakai Y., Yoshii S., Nagasaka S., et al. Interleukin 6, adiponectin, leptin, and insulin resistance in nonobese Japanese type 2 diabetes. Metabolism 2006, 55:258-262.
13. Ohya M., Taniguchi A., Fukushima M., Nakai Y., Kawasaki Y., Nagasaka S., et al. Three measures of tumor necrosis factor α activity and insulin resistance in nonobese Japanese patients with type 2 diabetes. Metabolism 2005, 54:1297-1301.
14. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Tsukamoto Y., et al. Modification of the MDRD Study equation for Japan. Am J Kidney Dis 2007, 46:923-927.
15. Seino Y., Nanjo K., Tajima N., Kadowaki T., Kashiwagi A., Araki E., et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. J Diabetes Investig 2010, 1:212-228.
16. Seino Y., Nanjo K., Tajima N., Kadowaki T., Kashiwagi A., Araki E., et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus. Diabetol Int 2010, 1:2-20.
17. Chronic Kidney Disease Prognosis Consortium: association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010, 375:2073-2081.
18. Ninomiya T., Perkovic V., de Galen B.E., Zoungas S., Pillai A., Jardine M., et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 2009, 20:1813-1821.
19. So W.Y., Kong A.P.S., Ma R.C.W., Ozaki R., Szeto C.C., Chan N.N., et al. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetes. Diabetes Care 2006, 29:2046-2052.
20. Taniguchi A., Fukushima M., Nakai Y., Ohgushi M., Kuroe A., Ohya M., et al. Soluble tumor necrosis factor receptor 1 is strongly and independently associated with serum homocysteine in nonobese Japanese type 2 diabetic patients. Diabetes Care 2006, 29:949-950. [Letter].
21. Joussen A.M., Poulaki V., Le M.L., Koizumi K., Esser C., Janicki H., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004, 18:1450-1452.
22. Gohda T, Niewczas M, Ficociello L, Walker WH, Skupien J, Rosetti F, et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol,. doi:10.1681/ASN.2011060628.
23. Navarro J.F., Mora-Fernandez C. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev 2006, 17:441-450.
24. Navarro J.F., Mora C. Role of inflammation in diabetic complications. Nephrol Dial Transplant 2005, 20:2601-2604.
25. Navarro J.F., Mora C., Gomez M., Muros M., Lopez-Aguilar C., Garcia J. Influence of renal involvement on peripheral blood mononuclear cell expression behavior of tumor necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Nephrol Dial Transplant 2008, 23:919-926.
26. Bertani T., Abbate M., Zoja C., Corna D., Perico N., Ghezzi P., et al. Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989, 134:419-430.
27. Karkar A.M., Smith J., Pusey C.D. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumor necrosis factor-alpha. Nephrol Dial Transplant 2001, 16:518-524.
28. Karkar A.M., Koshino Y., Cashman S.J., Dash A.C., Bonnefoy J., Meager A. Passive immunization against tumor necrosis factor-alpha (TNF-alpha) and IL-1 beta protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol 1989, 90:312-318.
29. Navarro J.F., Mora C., Maca M., Garcia J. Inflammatory parameters are independently associated with urinary albumin n type 2 diabetes mellitus. Am J Kidney Dis 2003, 42:53-61.
30. Bemelmans M.H., Gouma D.J., Buurman W.A. Tissue distribution and clearance of soluble murine TNF receptors in mice. Cytokine 1994, 6:608-615.
31. Niewczas M.A., Gohda T., Skupien J., Smiles A.M., Walker W.H., Rosetti F., et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol 2012, 23:507-515.
32. Vielhauer V., Stavrakis G., Mayadas T.N. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005, 115:1199-1209.
33. Upadhyay A., Larson M.G., Guo C.-Y., Vasan R.S., Lipinska I., O'Donnell C.J., et al. Inflammation, kidney function and albuminuria in the Framingham offspring cohort. Nephrol Dial Transplant 2011, 26:920-926.
34. Taniguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I., et al. Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 1992, 41:1540-1546.
35. Nagasaka S., Tokuyama K., Kusaka I., Hayashi H., Rokkaku K., Nakamura T., et al. Endogenous glucose production and glucose effectiveness in type 2 diabetic subjects derived from stable-labeled minimal model approach. Diabetes 1999, 48:1054-1060.